Petrucci Scatolini, Giovanna
 Distribuzione geografica
Continente #
NA - Nord America 2.286
AS - Asia 2.004
EU - Europa 1.983
SA - Sud America 395
AF - Africa 55
OC - Oceania 13
Continente sconosciuto - Info sul continente non disponibili 3
Totale 6.739
Nazione #
US - Stati Uniti d'America 2.218
SG - Singapore 904
DE - Germania 560
CN - Cina 505
IT - Italia 370
BR - Brasile 317
SE - Svezia 301
VN - Vietnam 168
FR - Francia 159
UA - Ucraina 133
GB - Regno Unito 109
IE - Irlanda 84
IN - India 72
FI - Finlandia 66
ID - Indonesia 66
RU - Federazione Russa 57
HK - Hong Kong 47
TR - Turchia 45
JP - Giappone 39
CA - Canada 36
AR - Argentina 32
BD - Bangladesh 31
BE - Belgio 25
IQ - Iraq 22
NL - Olanda 22
CZ - Repubblica Ceca 21
KR - Corea 19
AT - Austria 17
ES - Italia 17
ZA - Sudafrica 16
MX - Messico 15
PK - Pakistan 14
EC - Ecuador 13
IR - Iran 12
AU - Australia 11
PH - Filippine 11
SA - Arabia Saudita 11
PL - Polonia 10
CI - Costa d'Avorio 8
VE - Venezuela 8
CL - Cile 6
CH - Svizzera 5
CO - Colombia 5
EG - Egitto 5
LV - Lettonia 5
BG - Bulgaria 4
BO - Bolivia 4
HN - Honduras 4
KE - Kenya 4
LT - Lituania 4
MY - Malesia 4
NI - Nicaragua 4
NO - Norvegia 4
NP - Nepal 4
PY - Paraguay 4
UY - Uruguay 4
AZ - Azerbaigian 3
DZ - Algeria 3
ET - Etiopia 3
IL - Israele 3
JO - Giordania 3
KZ - Kazakistan 3
MA - Marocco 3
NG - Nigeria 3
SN - Senegal 3
TN - Tunisia 3
AE - Emirati Arabi Uniti 2
BY - Bielorussia 2
CG - Congo 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
EU - Europa 2
LB - Libano 2
NZ - Nuova Zelanda 2
OM - Oman 2
PE - Perù 2
TT - Trinidad e Tobago 2
YE - Yemen 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AM - Armenia 1
AO - Angola 1
BB - Barbados 1
BH - Bahrain 1
CR - Costa Rica 1
CY - Cipro 1
EE - Estonia 1
GR - Grecia 1
HU - Ungheria 1
JM - Giamaica 1
KH - Cambogia 1
KW - Kuwait 1
LK - Sri Lanka 1
PA - Panama 1
QA - Qatar 1
RO - Romania 1
RS - Serbia 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TJ - Tagikistan 1
Totale 6.737
Città #
Singapore 496
Ashburn 304
Chandler 289
San Jose 237
Beijing 91
Rome 83
Dublin 78
San Mateo 74
St Louis 73
Jacksonville 69
Los Angeles 60
Milan 57
Nanjing 56
Cattolica 55
Jakarta 55
Ho Chi Minh City 54
Ann Arbor 53
Munich 53
Hefei 51
Lauterbourg 48
Wilmington 46
Hong Kong 43
Hanoi 41
New York 41
Frankfurt am Main 37
Tokyo 37
Boston 35
Moscow 34
Dearborn 29
The Dalles 28
São Paulo 26
Woodbridge 26
Dallas 25
Nürnberg 25
Princeton 24
Houston 23
Helsinki 22
Bremen 20
Brno 20
Brussels 20
Council Bluffs 20
Hounslow 20
Nanchang 20
Izmir 18
Bareggio 17
Chicago 17
Lawrence 17
Redwood City 17
Tianjin 17
Kent 16
Paris 16
Turku 16
Hyderabad 15
Seoul 15
Fairfield 14
London 13
Orem 13
Redmond 13
Shenyang 13
Seattle 12
Amsterdam 11
Buffalo 11
Da Nang 11
Hebei 11
Kunming 11
Nuremberg 11
Santa Clara 11
Verona 11
Guangzhou 10
Vienna 10
Augusta 9
Belo Horizonte 9
Busto Arsizio 9
Lancaster 9
Manchester 9
Stockholm 9
Zhengzhou 9
Abidjan 8
Dhaka 8
Haiphong 8
Johannesburg 8
Mexico City 8
Montreal 8
Mountain View 8
Shanghai 8
Baghdad 7
Brooklyn 7
Bursa 7
Denver 7
Hangzhou 7
Istanbul 7
Jinan 7
Marseille 7
Phoenix 7
Warsaw 7
Ankara 6
Bexley 6
Chennai 6
Düsseldorf 6
Lahore 6
Totale 3.592
Nome #
Qualitative and quantitative modifications of von willebrand factor in patients with essential thrombocythemia and controlled platelet count 331
A randomized, double-blind trial of three aspirin regimens to optimize antiplatelet therapy in essential thrombocythemia 221
Obesity is associated with in vivo platelet activation and impaired responsiveness to once-daily, low-dose aspirin 195
The recovery of platelet cyclooxygenase activity explains interindividual variability in responsiveness to low-dose aspirin in patients with and without diabetes 193
Different STAT-3 and STAT-5 phosphorylation discriminates among Ph-negative chronic myeloproliferative diseases and is independent of the V617F JAK-2 mutation. 183
Prostaglandin E2 differentially modulates human platelet function through the prostanoid EP2 and EP3 receptors 177
Aspirin-insensitive thromboxane biosynthesis in essential thrombocythemia is explained by accelerated renewal of the drug target 171
In vivo platelet activation and aspirin responsiveness in type 1 diabetes mellitus 171
Phosphorylated STAT5 represents a new possible prognostic marker in Hodgkin lymphoma. 168
In Vivo Platelet Activation and Aspirin Responsiveness in Type 1 Diabetes 168
Abnormal megakaryopoiesis and platelet function in cyclooxygenase-2-deficient mice 165
The Aspirin Regimens in Essential Thrombocythemia (ARES) phase II randomized trial design: Implementation of the serum thromboxane B(2) assay as an evaluation tool of different aspirin dosing regimens in the clinical setting 161
Patient-independent variables affecting the assessment of aspirin responsiveness by serum thromboxane measurement 160
Pseudo-acquired vWD in essential thrombocythemia: the role of platelets 155
Patient-independent variables affecting the assessment of aspirin responsiveness by serum thromboxane measurement 146
In vivo thromboxane-dependent platelet activation is persistently enhanced in subjects with impaired glucose tolerance 143
Role of Oxidative Stress in the Pathogenesis of Atherothrombotic Diseases 131
Effects of low-dose rivaroxaban combined with low-dose aspirin versus low-dose aspirin alone on in vivo platelet activation, endothelial function and inflammation in type 2 diabetes patients with stable atherosclerotic disease: the RivAsa randomized, crossover study 128
Aspirin inhibits cancer stem cells properties and growth of glioblastoma multiforme through Rb1 pathway modulation 126
Preoperative psychological characteristics affecting mid-term outcome after bariatric surgery: a follow-up study 122
Effect of very long-term storage and multiple freeze and thaw cycles on 11-dehydro-thromboxane-B2 and 8-iso-prostaglandin F2α, levels in human urine samples by validated enzyme immunoassays 121
Aspirin, stroke and drug-drug interactions 121
The contribution of cyclooxygenase-1 and -2 to persistent thromboxane biosynthesis in aspirin-treated essential thrombocythemia: implications for antiplatelet therapy 119
Cystic fibrosis transmembrane conductance regulator (CFTR) expression in human platelets: impact on mediators and mechanisms of the inflammatory response 118
Tumorigenic potential of olfactory bulb-derived human adult neural stem cells associates with activation of TERT and NOTCH1. 115
Increased von Willebrand factor levels in polycythemia vera and phenotypic differences with essential thrombocythemia 112
Association of Platelet Thromboxane Inhibition by Low-Dose Aspirin With Platelet Count and Cytoreductive Therapy in Essential Thrombocythemia 111
On-pump Cardiac Surgery Enhances Platelet Renewal and Impairs Aspirin Pharmacodynamics: Effects of Improved Dosing Regimens 110
Aspirin inhibits proliferation and promotes differentiation of neuroblastoma cells via p21Waf1 protein up-regulation and Rb1 pathway modulation. 110
Stability of the thromboxane B2 biomarker of low-dose aspirin pharmacodynamics in human whole blood and in long-term stored serum samples 109
Thromboxane biosynthesis and future events in diabetes: the ASCEND trial 108
Role of Oxidative Stress in the Pathogenesis of Atherothrombotic Diseases 107
Prolonged fasting promotes systemic inflammation and platelet activation in humans: a medically supervised, water-only fasting and refeeding study 105
influence of local environment on the differentiation of neuronal stem cells engrafted onto the injured spinal cord 101
Phosphorylated STAT5 represents a new possible prognostic marker in Hodgkin lymphoma 101
In vivo thromboxane-dependent platelet activation is persistently enhanced in subjects with impaired glucose tolerance 99
Effect of low-dose and standard-dose aspirin on PGE2 biosynthesis among individuals with colorectal adenomas: A randomized clinical trial 99
Platelet thromboxane inhibition by low-dose aspirin in polycythemia vera: Ex vivo and in vivo measurements and in silico simulation 97
Obesity is associated with impaired responsiveness to once-daily low-dose aspirin and in vivo platelet activation 96
Long-term pharmacodynamic and clinical effects of twice- versus once-daily low-dose aspirin in essential thrombocythemia: The ARES trial 96
Stability of urinary thromboxane A2 metabolites and adaptation of the extraction method to small urine volume 93
Aspirin-insensitive thromboxane biosynthesis in essential thrombocythemia is explained by accelerated renewal of the drug target 92
Thromboxane biosynthesis in cancer patients and its inhibition by aspirin: a sub-study of the Add-Aspirin trial 88
Inhibition of telomerase in the endothelial cells disrupts tumor angiogenesis in glioblastoma xenografts 87
On-pump Cardiac Surgery Enhances Platelet Renewal and Impairs Aspirin Pharmacodynamics: Effects of Improved Dosing Regimens 87
Mesenchymal differentiation of glioblastoma stem cells 86
Pathophysiology of Thrombosis in Peripheral Artery Disease 86
Variability in the Responsiveness to Low-Dose Aspirin: Pharmacological and Disease-Related Mechanisms. 85
Physiologically based modelling of the antiplatelet effect of aspirin: A tool to characterize drug responsiveness and inform precision dosing 83
Pathophysiology of Thrombosis in Peripheral Artery Disease 76
Establishing tumor cell lines from aggressive telomerase-positive chordomas of the skull base: Technical note 74
Very-low-dose twice-daily aspirin maintains platelet inhibition and improves haemostasis during dual-antiplatelet therapy for acute coronary syndrome 73
Physiologically based modelling of the antiplatelet effect of aspirin: A tool to characterize drug responsiveness and inform precision dosing 69
Personalized medicine, pharmacogenetics, and clopidogrel: unraveling variability of response 68
Influence of local environment on the differentiation of neural stem cells engrafted onto the injured spinal cord 67
Mesenchymal differentiation of glioblastoma stem cells 62
Totale 6.846
Categoria #
all - tutte 26.469
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.469


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202185 0 0 0 0 0 0 0 0 0 13 51 21
2021/2022390 40 18 5 24 30 10 10 85 14 19 59 76
2022/2023808 105 116 69 118 61 89 26 70 100 18 22 14
2023/2024507 15 108 19 58 44 46 31 16 15 25 51 79
2024/20251.066 28 24 68 49 103 30 17 81 136 88 252 190
2025/20262.588 392 87 214 324 422 122 500 121 198 208 0 0
Totale 6.846